Lijuan Zeng, M.H.S., joined Statistics Collaborative, Inc. (SCI) in 2015. She is a member of the Society for Clinical Trials and the American Statistical Association.
At SCI, Ms. Zeng has contributed to clinical trials in several disease areas, including oncology and cardiovascular, metabolic, hematological, respiratory, ophthalmological, and autoimmune diseases. As a biostatistician, she performs statistical analyses, programs CDISC-compliant datasets, validates program code, develops and audits SAS macros, develops R shiny apps, and writes study reports, statistical analysis plans, and meeting minutes. Ms. Zeng has served as project manager and independent reporting statistician for for several Phase 2 and Phase 3 trials. In this role, she manages multiple projects, including statistical, finanical, contractual, and personnel aspects of projects.
Prior to joining SCI, Ms. Zeng worked as a research assistant for the Center for Clinical Trials and Evidence Synthesis at Johns Hopkins University. In this position, she collaborated with the National Institutes of Health to evaluate the quality of registration of clinical trials on ClinicalTrials.gov. She also worked on systematic reviews and meta-analysis projects for the Cochrane Eyes and Vision Group. She was a teaching assistant for three graduate level courses: Conduct and Design of Clinical Trials, Introduction to Clinical Trials, and Pharmacoepidemiology Methods.
Ms. Zeng received her B.S. summa cum laude in Pharmaceutical Science from Fudan University (2013) and her M.H.S. in Epidemiology (concentration in Clinical Trials and Evidence Synthesis) with a certificate in Pharmacoepidemiology and Drug Safety from Johns Hopkins Bloomberg School of Public Health (2015).
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.